89bio, Inc.
ETNB
$8.45
$0.2653.24%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -158.16% | -128.33% | -47.18% | -56.73% | -39.37% |
| Total Depreciation and Amortization | -24.00% | -8.16% | -14.55% | -26.23% | -23.08% |
| Total Amortization of Deferred Charges | -4.92% | -44.48% | -29.96% | -10.02% | 14.40% |
| Total Other Non-Cash Items | 13.07% | 10.74% | -8.57% | -5.18% | 19.59% |
| Change in Net Operating Assets | -2,311.26% | 43.66% | -643.79% | 121.10% | -93.78% |
| Cash from Operations | -184.72% | -129.97% | -55.52% | -59.87% | -59.31% |
| Capital Expenditure | -275.00% | -100.00% | -100.00% | -300.00% | 42.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.79% | -76.51% | 48.71% | -265.71% | -262.49% |
| Cash from Investing | 66.78% | -76.51% | 48.70% | -265.71% | -262.43% |
| Total Debt Issued | -61.63% | -61.63% | -100.00% | -100.00% | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -58.60% | -36.00% | -51.57% | -50.62% | 333.80% |
| Repurchase of Common Stock | -15.59% | -6.61% | -260.30% | -231.28% | -668.46% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.40% | -34.31% | -52.57% | -51.65% | 335.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -172.86% | -189.41% | -117.98% | -145.05% | 9,224.73% |
